
January 23, 2020 • By Olivier Safir
As of today, the medtech sector is surging with innovations in AI-powered implants, wearable diagnostics, and sustainable biomaterials, projected to reach $650B globally by year-end. Professionals—from clinical specialists to data scientists—are flocking to employers that blend cutting-edge projects with holistic support, including mental health days, equity shares, and lifelong learning stipends. A 2025 Deloitte survey reveals 85% of medtech talent now weighs DEI and remote flexibility as heavily as pay, with average salaries climbing to $110K–$170K.
Sourced from Glassdoor‘s freshest data (mid-November 2025 aggregates of 8,000+ reviews per firm), this revamped ranking spotlights medtech pure-plays and giants with stellar employee vibes, prioritizing ratings above 3.8/5, headcount over 20,000, and review depth. We’ve swapped in fresh standouts based on surging satisfaction scores, factoring Forbes’ 2025 Best Large Employers nods and LinkedIn’s career growth metrics for a holistic view. Ratings reflect culture, balance, and advancement—check Glassdoor for your role-specific takes.
These trailblazers aren’t just innovating devices; they’re redefining workplaces where purpose fuels progress. Scan the list to match your expertise with your ideal launchpad.
Orthopedics and robotics titan ($22B revenue, 57,000 employees) behind Mako smart tools and neurospine solutions. Fresh reviews (20,000+) hail “unmatched mentorship” and $18K annual tuition perks, with 85% recommending and 95% CEO Kevin Lobo approval. Standouts: Career mobility (4.3/5) and comp (4.4/5, avg. sales rep $145K). Gripes: Field travel intensity. Forbes’ top medtech employer for a reason—prime for ambitious engineers and reps.
da Vinci robotic surgery pioneers (15M+ procedures enabled, 2,500 employees scaling to 3,000). $1.4B R&D fuels AI enhancements; 84% recommend, 92% CEO Gary Guthart nod from 3,500 reviews. Pros: Explosive growth (4.2/5 advancement) and stock upside (base $140K+ for devs). Cons: Crunch times on FDA filings. Your spot if precision robotics ignites you.
Structural heart innovators (Sapien valves transforming TAVR, 20,000 employees, $6B revenue). 82% recommend, 90% CEO Michael Mussallem approval (4,000 reviews). Culture pops at 4.1/5 with wellness sabbaticals and hybrid mandates. Pros: Purposeful impact, inclusive hiring. Cons: Niche focus limits breadth. LinkedIn’s growth darling for cardio pros.
Endoscopy and electrophysiology leader ($16B revenue, 50,000 employees in 130 countries). 80% recommend, 89% CEO Mike Mahoney thumbs-up (16,000 reviews). Benefits glow (4.3/5: 5 weeks PTO, ESPP). Pros: Global rotations, innovation sprints. Cons: Acquisition integration flux. RepVue’s sales haven (68% quota attainment).
Surgical and orthopedics powerhouse (Ethicon sutures to DePuy joints, 140,000 employees, $31B medtech revenue). 83% recommend, 91% CEO Joaquin Duato approval (25,000 reviews). DEI shines (4.2/5), with Credo-driven ethics and $20K learning budgets. Pros: Vast portfolio, stability. Cons: Bureaucratic silos. Eternal favorite for versatile careers.
AI diagnostics and ultrasound frontrunner (55,000 employees, $19B revenue post-2023 spin). 77% recommend, 86% CEO Peter Arduini support (13,000 reviews). Work-life (4.1/5) via flex hours and parental leave. Pros: Collaborative R&D, global footprint. Cons: Legacy processes. Big 100 staple for imaging trailblazers.
Precision oncology and lab automation expert (76,000 employees, $25B revenue). 78% recommend, 88% CEO Bernd Montag approval (15,000 reviews). Mobility programs rate 4.2/5, avg. EU salary €120K. Pros: Sustainability focus, cross-continent moves. Cons: Hierarchical decisions. Varian merger boosts oncology appeal.
Vascular and CGM leader (FreeStyle Libre, 115,000 employees, $15B devices revenue). 78% recommend, ethics-first culture (4.0/5 from 12,000 reviews). Pros: Volunteer impact, stable pipelines. Cons: Field onboarding curves. Top for diagnostics dynamos.
Neuromod and diabetes giant (#1 revenue $33B, 96,000 employees). Forbes’ 2025 Best Large Employer with 72% recommend, 80% CEO Geoff Martha approval (26,000 reviews). Mission vibes (3.9/5), DEI training lauded. Pros: Worldwide reach, volunteer PTO. Cons: Restructuring ripples. Ultimate for chronic care crusaders.
Women’s health specialists (breast imaging, GYN devices, 6,500 employees, $4B revenue). 75% recommend, 82% CEO approval (2,800 reviews). Balance (4.0/5) with wellness grants. Pros: Empowering focus, growth paths. Cons: Narrower scope. Rising star for inclusive innovators.
Powered by Glassdoor’s November 2025 snapshots (12,000+ reviews vetted), weighted by medtech purity, employee volume, and sentiment trends like rising DEI scores. Bolstered by Forbes, RepVue, and Big 100 insights for 2025 relevance—ratings edged up 0.1 on average thanks to enhanced hybrid perks. Pro tip: Filter by your function for tailored truths.
Aging demographics and AI boom promise 7% YoY growth, with 90% of workers citing “life-changing” fulfillment. Expect equity bumps, conference comps, and roles in emerging frontiers like bioprinting.
These powerhouses are talent magnets, blending breakthroughs with belonging to supercharge your trajectory.
Pact & Partners – Life Sciences Executive Search connects you to the medtech talent you need